Dr. Danuta Jarocha
Dr. Jarocha has a long-lasting interest in stem cells and their use in regenerative medicine. She completed her PhD in Medical Biology and Experimental Hematology at the Pomeranian Medical University in Szczecin, Poland under the supervision of Professor Mariusz Ratajczak. During her time there she studied stem cells isolated from thymus. For several years, she was a part of a transplantation team at the Hematopoietic Stem Cells Transplantation Department at Children’s Hospital in Krakow, Poland. At the same time, she studied biology of mesenchymal stem cells (MSC), which led to the development of MSC-based experimental cell therapy protocols successfully studied in GVHD, spinal cord injury, drug resistant epilepsy as well as heart infarction treatment. Dr. Jarocha also established a large-scale muscle cells expansion protocol and actively participated in using autologous muscle cells transplantation in experimental treatment of urinary incontinence. After iPS technology development she joined Dr. Ponczs Lab and participated in projects using iPS-derived megakaryocytes to study role of Fli-1 TF in megakaryopoiesis and thrombopoiesis. She was also involved in iPS and CD34+cells-based studies aiming at developing in vitro grown megakaryocytes-based cell therapy product as an alternative for human donor platelet transfusions. Recently she joined Dr. Rivella's Lab to participate in gene therapy projects for hemoglobinopathies.